实时全球研报
The A2 Milk Company Ltd (A2M.AX): Good start to the week with two China label product registrations being successfully transferred to a2
研报英文原文证据摘录
The A2 Milk Company Ltd (A2M.AX): Good start to the week with two China label product registrations being successfully transferred to a2
Flash |
21 Jun 2026 21:07:56 ET │ 12 pages
The A2 Milk Company Ltd (A2M.AX)
Good start to the week with two China label product registrations being
successfully transferred to a2
CITI’S TAKE Neutral
While the SAMR approval to transition two China label product Price (19 Jun 26 16:00) A$6.71
registrations is broadly within Neutral-rated a2’s expected timeline of up Target price A$6.70
to 12 months from August 2025, we consider the approval to be
Expected share price return -0.1% particularly positive given i) there is always some degree of regulatory
uncertainty until these types of approvals come through, and ii) it unlocks Expected dividend yield 2.3%
a material special dividend. Expected total return 2.2%
Market Cap A$4,868M
What do the two registrations mean? The transition of these two infant formula US$3,414M
registrations i) brings the branding from existing Bellamy’s and Mengniu formulations
to a2, ii) should provide a2 a tailwind to grow its longer-term market share, as it can
contest the market with more products, iii) reduces the reliance on the underlying
market (i.e. birth rate) via additional products, iv) might help a2 optimise the way it Food & Beverage Team
serves the trade and v) helps de-risk a2’s China label from Synlait, where suboptimal
Sam TeegerACmanufacturing performance has been a contributing factor to a2’s supply
constraints. We would think it is unlikely that these products are launched prior to +61-2-8225-4319
Singles’ Day. sam.teeger@citi.com
Eileen Li
SAMR approval due next year. When SAMR registration renewal for these two
products are due in July 2027, we expect a2 to reformulate and upgrade these
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器